Home » Newsletters » BioWorld Science

BioWorld Science

April 20, 2011

View Archived Issues

PLATO subanalysis finds ticagrelor superior to clopidogrel in elderly patients with ACS

Interim first-in-human data disclosed on BioFreedom biolimus A9-eluting coronary stent

CTS-1027 shows promise to treat hepatitis C in treatment-naive and -experienced patients

Preclinical and clinical data presented on GS-9620 for hepatitis B and C

Cephalon advances in acquisition of ChemGenex Pharmaceuticals

New antibody-drug conjugate AGS-22M6E may be beneficial for treatment of solid tumors

Novel PI3K-alpha inhibitors patented by Roche for cancer

Merck KGaA designs new protein kinase inhibitors

Galderma synthesizes novel ADAM 17 inhibitors

Hyaluronidase-4 described as new predictor of bladder cancer progression

Anaphore's DR4 Atrimers have antitumor activity in vitro

Oryzon Genomics designs new inhibitors of lysine-specific histone demethylase 1A

Roche presents new inhibitors of HCV NS3 and NS4A

Biosearch designs new voltage-gated Na(V)1.3 and Na(V)1.8 sodium channel blockers

Phase III MARQUEE trial of tivantinib begins enrollment in Europe

VISTA-16 study of varespladib proceeds as planned after independent biomarker analysis

Novartis withdraws MAA for Joicela in osteoarthritis

GSK and Valeant Pharma submit response to FDA on ezogabine

Bristol-Myers Squibb begins phase I study of BMS-906024 in solid tumors

Celgene begins phase III trials of pomalidomide in multiple myeloma

AIDS Healthcare Foundation urges Gilead to halt Truvada approval in HIV prevention

NicOx withdraws European application for osteoarthritis candidate naproxcinod

Chugai Pharma receives priority review for Pegasys in new indication in chronic hepatitis B in Japan

FDA grants orphan status to AM-152 in idiopathic pulmonary fibrosis

CoDa Therapeutics raises funds for Nexagon trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...